Beginning Next Week: InsideCounsel will become part of Corporate Counsel. Bringing these two industry-leading websites together will now give you comprehensive coverage of the full spectrum of issues affecting today's General Counsel at companies of all sizes. You will continue to receive expert analysis on key issues including corporate litigation, labor developments, tech initiatives and intellectual property, as well as Women, Influence & Power in Law (WIPL) professional development content. Plus we'll be serving all ALM legal publications from one interconnected platform, powered by Law.com, giving you easy access to additional relevant content from other InsideCounsel sister publications.

To prevent a disruption in service, you will be automatically redirected to the new site next week. Thank you for being a valued InsideCounsel reader!

X

Paxil

  • Dr. Drew Pinsky paid by Glaxo to promote Wellbutrin

    Apparently there’s a link between depression and intimacy, and not just in the physiological sense. The Wall Street Journal reported Tuesday that popular radio and television personality Dr. Drew Pinksy had a somewhat intimate relationship with pharmaceutical company GlaxoSmithKline Plc (GSK), the maker of antidepressant Wellbutrin, in the late '90s.

  • Glaxo agrees to pay $956.8 million criminal fine

    It’s probably not the way GlaxoSmithKline (GSK) had hoped to start the second half of the year. The U.S. unit of GSK today agreed to plead guilty and pay a criminal fine of $956.8 million for marketing drugs for unapproved uses.

Advertisement. Closing in 15 seconds.